Skip to main content

Advertisement

SpringerLink
Log in

Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance

  • Published:
Neuropsychology Review Aims and scope Submit manuscript

Abstract

Cannabis has an ancient history of human use and is currently one of the most commonly used drugs worldwide. Understanding its impact on neurobehavioral functioning is of significant public health concern. In recent decades, substantial progress has been made in understanding the impact of cannabis use on neurobehavioral functioning. This has been fueled, in part, by characterization of an endocannabinoid signaling system in the brain through which cannabis exerts its psychoactive effects. Acute intoxication with cannabis causes marked changes in subjective mental status, brain functioning, and neuropsychological performance. Some of these changes are consistently detected and well characterized, yet others are not. Changes in brain functioning and neuropsychological performance are also reported after abstinence, but appear to be mild, circumscribed, and transient. On the other hand, functional neuroimaging often reveals subtle differences in the brain functioning of abstinent cannabis users compared with controls. The persistence and clinical significance of these differences, however, remains to be determined. Neuropsychological deficits and differences in brain functioning are most consistently observed only among frequent, heavy users, who are those most likely addicted to cannabis. The dire impact of drug addiction on a person’s life and everyday functioning suggests that the large number of individuals addicted to cannabis experience substantial negative effects from its use. This manuscript reviews the scientific literature on the aforementioned topics in detail, providing evidence for converging findings, and highlighting areas in need of further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aasly, J., Storsaeter, O., Nilsen, G., Smevik, O., & Rinck, P. (1993). Minor structural brain changes in young drug abusers. A magnetic resonance study. Acta Neurologica Scandanivica, 87, 210–214.

    Article  CAS  Google Scholar 

  • Agurell, S., Halldin, M., Lindgren, J. E., Ohlsson, A., Widman, M., Gillespie, H., et al. (1986). Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacology Review, 38, 21–43.

    CAS  Google Scholar 

  • Amen, D. G., & Waugh, M. (1998). High resolution brain SPECT imaging of marijuana smokers with AD/HD. Journal of Psychoactive Drugs, 30, 209–214.

    PubMed  CAS  Google Scholar 

  • Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology, 2, 244–268.

    Google Scholar 

  • Bechara, A., Dolan, S., Denburg, N., Hindes, A., Anderson, S. W., & Nathan, P. E. (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia, 39, 376–389.

    PubMed  CAS  Google Scholar 

  • Block, R. I., Erwin, W. J., Farinpour, R., & Braverman, K. (1998). Sedative, stimulant, and other subjective effects of marijuana: relationships to smoking techniques. Pharmacology Biochemistry and Behavior, 59, 405–412.

    CAS  Google Scholar 

  • Block, R. I., & Ghoneim, M. M. (1993). Effects of chronic marijuana use on human cognition. Psychopharmacology, 110, 219–228.

    PubMed  CAS  Google Scholar 

  • Block, R. I., O’Leary, D. S., Ehrhardt, J. C., Augustinack, J. C., Ghoneim, M. M., Arndt, S., et al. (2000a). Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport, 11, 491–496.

    Article  CAS  Google Scholar 

  • Block, R. I., O’Leary, D. S., Hichwa, R. D., Augustinack, J. C., Boles Ponto, L. L., Ghoneim, M. M., et al. (2002). Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacology Biochemistry and Behavior, 72, 237–250.

    CAS  Google Scholar 

  • Block, R. I., O’Leary, D. S., Hichwa, R. D., Augustinack, J. C., Ponto, L. L. B., Ghoneim, M. M., et al. (2000b). Cerebellar hypoactivity in frequent marijuana users. Neuroreport, 11, 749–753.

    Article  PubMed  CAS  Google Scholar 

  • Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002). Dose-related neurocognitive effects of marijuana use. Neurology, 59, 1337–1343.

    PubMed  CAS  Google Scholar 

  • Bolla, K. I., Eldreth, D. A., Matochik, J. A., & Cadet, J. L. (2005). Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage, 26, 480–492.

    PubMed  Google Scholar 

  • Bornovalova, M. A., Daughters, S. B., Hernandez, G. D., Richards, J. B., & Lejuez, C. W. (2005). Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program. Experimental and Clinical Psychopharmacology, 13, 311–318.

    PubMed  Google Scholar 

  • Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology, 60, 155–163.

    PubMed  CAS  Google Scholar 

  • Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161, 1967–1977.

    PubMed  Google Scholar 

  • Campbell, A. M., Evans, M., Thomson, J. L., & Williams, M. J. (1971). Cerebral atrophy in young cannabis smokers. Lancet, 2, 1219–1224.

    PubMed  CAS  Google Scholar 

  • Carlin, A. S., & Trupin, E. W. (1977). The effect of long-term chronic marijuana use on neuropsychological functioning. International Journal of the Addictions, 12, 617–624.

    PubMed  CAS  Google Scholar 

  • Chang, L., Yakupov, R., Cloak, C., & Ernst, T. (2006). Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain, 129, 1096–1112.

    PubMed  CAS  Google Scholar 

  • Chevaleyre, V., & Castillo, P. E. (2004). Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron, 43, 871–881.

    PubMed  CAS  Google Scholar 

  • Childers, S. R., Pacheco, M. A., Bennett, B. A., Edwards, T. A., Hampson, R. E., Mu, J., et al. (1993). Cannabinoid receptors: G-protein-mediated signal transduction mechanisms. Biochemical Society Symposia, 59, 27–50.

    CAS  Google Scholar 

  • Co, B. T., Goodwin, D. W., Gado, M., Mikhael, M., & Hill, S. Y. (1977). Absence of cerebral atrophy in chronic cannabis users. Evaluation by computerized transaxial tomography. Journal of the American Medical Association, 237, 1229–1230.

    PubMed  CAS  Google Scholar 

  • Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004). Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. Journal of the American Medical Association, 291, 2114–2121.

    PubMed  CAS  Google Scholar 

  • Crippa, J. A., Lacerda, A. L., Amaro, E., Busatto, F. G., Zuardi, A. W., & Bressan, R. A. (2005). Brain effects of cannabis-neuroimaging findings. Revista Brasileira de Psiquiatria, 27, 70–78.

    PubMed  Google Scholar 

  • Croft, R. J., Mackay, A. J., Mills, A. T. D., & Gruzelier, J. G. H. (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373–379.

    PubMed  CAS  Google Scholar 

  • Crowley, T. J., Raymond, K. M., Mikulich-Gilbertson, S. K., Thompson, L. L., & Lejuez, C. W. (2006). A risk-taking “set” in a novel task among adolescents with serious conduct and substance problems. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 175–183.

    PubMed  Google Scholar 

  • Davies, S. N., Pertwee, R. G., & Riedel, G. (2002). Functions of cannabinoid receptors in the hippocampus. Neuropharmacology, 42, 993–1007.

    PubMed  CAS  Google Scholar 

  • Deif, A., El, S. A., & Fawzy, R. K. (1993). Neurological, psychiatric and C.T. evaluation of chronic cannabis smokers. Journal of the Medical Research Institute, 14, 151–160.

    Google Scholar 

  • De Petrocellis, L., Cascio, M. G., & Di Marzo, V. (2004). The endocannabinoid system: a general view and latest additions. British Journal of Pharmacology, 141, 765–774.

    PubMed  Google Scholar 

  • Devane, W. A., Dysarz, F. A., III, Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology, 34, 605–613.

    PubMed  CAS  Google Scholar 

  • Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946–1949.

    PubMed  CAS  Google Scholar 

  • Di Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., et al. (2000). Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain. Journal of Neurochemistry, 75, 2434–2444.

    PubMed  Google Scholar 

  • Ehrenreich, H., Rinn, T., Kunert, H. J., Moeller, M. R., Poser, W., Schilling, L., et al. (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology, 142, 295–301.

    PubMed  CAS  Google Scholar 

  • Eldreth, D. A., Matochik, J. A., Cadet, J. L., & Bolla, K. I. (2004). Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage, 23, 914–920.

    PubMed  Google Scholar 

  • Ellis, G. M., Jr., Mann, M. A., Judson, B. A., Schramm, N. T., & Tashchian, A. (1985). Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clinical Pharmacology and Therapeutics, 38, 572–578.

    Article  PubMed  CAS  Google Scholar 

  • ElSohly, M. A., Ross, S. A., Mehmedic, Z., Arafat, R., Yi, B., & Banahan, B. F. (2000). Potency trends of Delta(9)-THC and other cannabinoids in confiscated marijuana from 1980–1997. Journal of Forensic Sciences, 45, 24–30.

    PubMed  CAS  Google Scholar 

  • ElSohly, M. A., & Slade, D. (2005). Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sciences, 78, 539–548.

    PubMed  CAS  Google Scholar 

  • Eubanks, L. M., Rogers, C. J., Beuscher, A. E., Koob, G. F., Olson, A. J., Dickerson, T. J., et al. (2006). A molecular link between the active component of marijuana and Alzheimer’s disease pathology. Molecular Pharmacology, 3, 773–777.

    CAS  Google Scholar 

  • European Monitoring Centre for Drugs and Drug Addiction. (2004). Annual Report 2004: The state of the drugs problem in the European Union and Norway Luxembourg: Office for Official Publications of the European Communities.

  • Ferraro, D. P. (1980). Acute effects of marijuana on human memory and cognition. In R. C.Petersen (Ed.), Marijuana research findings: 1980. Washington D.C.: Department of Health and Human Services.

    Google Scholar 

  • Fillmore, M. T., & Rush, C. R. (2002). Impaired inhibitory control of behavior in chronic cocaine users. Drug and Alcohol Dependence, 66, 265–273.

    PubMed  Google Scholar 

  • Fisk, J. E., Montgomery, C., Wareing, M., & Murphy, P. N. (2006). The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic? Human Psychopharmacology, 21, 355–366.

    PubMed  CAS  Google Scholar 

  • Fletcher, J. M., Page, J. B., Francis, D. J., Copeland, K., Naus, M. J., Davis, C. M., et al. (1996). Cognitive correlates of long-term cannabis use in Costa Rican men. Archives of General Psychiatry, 53, 1051–1057.

    PubMed  CAS  Google Scholar 

  • Fride, E., Foox, A., Rosenberg, E., Faigenboim, M., Cohen, V., Barda, L., et al. (2003). Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a “CB3” receptor. European Journal of Pharmacology, 461, 27–34.

    PubMed  CAS  Google Scholar 

  • Fried, P. A., & Smith, A. M. (2001). A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicology and Teratology, 23, 1–11.

    PubMed  CAS  Google Scholar 

  • Fried, P. A., Watkinson, B., & Gray, R. (2005). Neurocognitive consequences of marihuana—a comparison with pre-drug performance. Neurotoxicology and Teratology, 27, 231–239.

    PubMed  CAS  Google Scholar 

  • Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., et al. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. European Journal of Biochemistry, 232, 54–61.

    PubMed  CAS  Google Scholar 

  • Glass, M., Brotchie, J. M., & Maneuf, Y. P. (1997a). Modulation of neurotransmission by cannabinoids in the basal ganglia. Eureopean Journal of Neuroscience, 9, 199–203.

    PubMed  CAS  Google Scholar 

  • Glass, M., Dragunow, M., & Faull, R. L. (1997b). Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 77, 299–318.

    PubMed  CAS  Google Scholar 

  • Gonzalez, R., Bechara, A., & Martin, E. M. (2007). Executive functions among individuals with methamphetamine or alcohol as drugs of choice: Preliminary observations. Journal of Clininical and Experimental Neuropsychology, 29, 155–159.

    Google Scholar 

  • Gonzalez, R., Carey, C., & Grant, I. (2002). Nonacute (Residual) neuropsychological effects of cannabis use: A qualitative analysis and systematic review. Journal of Clinical Pharmacology, 42, 48S–57S.

    PubMed  CAS  Google Scholar 

  • Gonzalez, S., Cebeira, M., & Fernandez-Ruiz, J. (2005). Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacology Biochemistry and Behavior, 81, 300–318.

    CAS  Google Scholar 

  • Gonzalez, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B. C., et al. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence, 76, 181–190.

    PubMed  CAS  Google Scholar 

  • Gouzoulis-Mayfrank, E., Daumann, J., Tuchtenhagen, F., Pelz, S., Becker, S., Kunert, H. J., et al. (2000). Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery and Psychiatry, 68, 719–725.

    CAS  Google Scholar 

  • Grant, I. & Cahn, B. R. (2005). Cannabis and endocannabinoid modulators: Therapeutic promises and challenges. Clinical Neuroscience Research, 5(2–4), 185–199.

    CAS  PubMed  Google Scholar 

  • Grant, S., Contoreggi, C., & London, E. D. (2000). Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia, 38, 1180–1187.

    PubMed  CAS  Google Scholar 

  • Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society, 9, 679–689.

    PubMed  CAS  Google Scholar 

  • Grant, I., Rochford, J., Fleming, T., & Stunkard, A. (1973). A neuropsychological assessment of the effects of moderate marihuana use. Journal of Nervous & Mental Disease, 156, 278–280.

    Article  CAS  Google Scholar 

  • Green, B., Kavanagh, D., & Young, R. (2003). Being stoned: a review of self-reported cannabis effects. Drug and Alcohol Review, 22, 453–460.

    PubMed  Google Scholar 

  • Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42, 327–360.

    PubMed  CAS  Google Scholar 

  • Gruber, S. A., & Yurgelun-Todd, D. A. (2005). Neuroimaging of marijuana smokers during inhibitory processing: A pilot investigation. Brain Research, 23, 107–118.

    PubMed  Google Scholar 

  • Grundy, R. I. (2002). The therapeutic potential of the cannabinoids in neuroprotection. Expert Opinions on Investigational Drugs, 11, 1365–1374.

    CAS  Google Scholar 

  • Guzman, M., Sanchez, C., & Galve-Roperh, I. (2001). Control of the cell survival/death decision by cannabinoids. Journal of Molecular Medicine, 78, 613–625.

    PubMed  CAS  Google Scholar 

  • Hamil, W. L. (1996). Auditory learning and memory performance among veterans with a history of stimulant abuse. Dissertation Abstracts International: Section B: The Sciences & Engineering, 56, 5806.

    Google Scholar 

  • Hampson, A. J., Grimaldi, M., Lolic, M., Wink, D., Rosenthal, R., & Axelrod, J. (2000). Neuroprotective antioxidants from marijuana. Annals of the New York Academy of Sciences, 899, 274–282.

    Article  PubMed  CAS  Google Scholar 

  • Hannerz, J., & Hindmarsh, T. (1983). Neurological and neuroradiological examination of chronic cannabis smokers. Annals of Neurology, 13, 207–210.

    PubMed  CAS  Google Scholar 

  • Hanus, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., et al. (2001). 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proceedings of the National Academy of Sciences of the United States of America, 98, 3662–3665.

    PubMed  CAS  Google Scholar 

  • Heishman, S. J., Stitzer, M. L., & Yingling, J. E. (1989). Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacology Biochemistry and Behavior, 34, 173–179.

    CAS  Google Scholar 

  • Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., et al. (1990). Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences, 87, 1932–1936.

    CAS  Google Scholar 

  • Hermann, D., Sartorius, A., Welzel, H., Walter, S., Skopp, G., Ende, G., et al. (2007). Dorsolateral prefrontal cortex n-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biolgical Psychiatry, 61, 1281–1289.

    CAS  Google Scholar 

  • Herning, R. I., Hooker, W. D., & Jones, R. T. (1986). Tetrahydrocannabinol content and differences in marijuana smoking behavior. Psychopharmacology, 90, 160–162.

    PubMed  CAS  Google Scholar 

  • Huestis, M. A., Mitchell, J. M., & Cone, E. J. (1996). Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. Journal of Analytical Toxicology, 20, 441–452.

    PubMed  CAS  Google Scholar 

  • Iversen, L. L. (2000). The science of marijuana. New York: Oxford University Press.

    Google Scholar 

  • Jager, G., Kahn, R. S., Van Den, B. W., Van Ree, J. M., & Ramsey, N. F. (2006). Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology, 185, 358–368.

    PubMed  CAS  Google Scholar 

  • Jager, G., Van Hell, H. H., De Win, M. M., Kahn, R. S., Van Den, B. W., Van Ree, J. M., et al. (2007). Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology, 17, 289–297.

    PubMed  CAS  Google Scholar 

  • Jiang, H. E., Li, X., Zhao, Y. X., Ferguson, D. K., Hueber, F., Bera, S., et al. (2006). A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China. Journal of Ethnopharmacology, 108, 414–422.

    PubMed  Google Scholar 

  • Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2006). Monitoring the future study. Washington, DC: NIDA.

    Google Scholar 

  • Kanayama, G., Rogowska, J., Pope, H. G., Gruber, S. A., & Yurgelun-Todd, D. A. (2004). Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study. Psychopharmacology, 176, 239–247.

    PubMed  CAS  Google Scholar 

  • Kelleher, L. M., Stough, C., Sergejew, A. A., & Rolfe, T. (2004). The effects of cannabis on information-processing speed. Addictive Behaviors, 29, 1213–1219.

    PubMed  Google Scholar 

  • Kirby, K. N., Petry, N. M., & Bickel, W. K. (1999). Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. Journal of Experimental Psychology-General, 128, 78–87.

    PubMed  CAS  Google Scholar 

  • Kuehnle, J., Mendelson, J. H., Davis, K. R., & New, P. F. (1977). Computed tomographic examination of heavy marijuana smokers. Journal of the American Medical Association, 237, 1231–1232.

    PubMed  CAS  Google Scholar 

  • Landfield, P. W., Cadwallader, L. B., & Vinsant, S. (1988). Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: Possible mediation by glucocorticoid systems. Brain Research, 443, 47–62.

    PubMed  CAS  Google Scholar 

  • Lane, S. D., Cherek, D. R., Tcheremissine, O. V., Lieving, L. M., & Pietras, C. J. (2005). Acute marijuana effects on human risk taking. Neuropsychopharmacology, 30, 800–809.

    PubMed  CAS  Google Scholar 

  • Lawston, J., Borella, A., Robinson, J. K., & Whitaker-Azmitia, P. M. (2000). Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2. Brain Research, 877, 407–410.

    PubMed  CAS  Google Scholar 

  • Leshner, A. I. (1997). Addiction is a brain disease, and it matters. Science, 278, 45–47

    PubMed  CAS  Google Scholar 

  • Loeber, R. T. & Yurgelun-Todd, D. A. (1999). Human neuroimaging of acute and chronic marijuana use: Implications for frontocerebellar dysfunction. Human Psychopharmacology-Clinical and Experimental, 14, 291–304.

    CAS  Google Scholar 

  • Lundqvist, T., Jonsson, S., & Warkentin, S. (2001). Frontal lobe dysfunction in long-term cannabis users. Neurotoxicology and Teratology, 23, 437–443.

    PubMed  CAS  Google Scholar 

  • Lyons, M. J., Bar, J. L., Panizzon, M. S., Toomey, R., Eisen, S., Xian, H., et al. (2004). Neuropsychological consequences of regular marijuana use: A twin study. Psychological Medicine, 34, 1239–1250.

    PubMed  CAS  Google Scholar 

  • Madden, G. J., Petry, N. M., Badger, G. J., & Bickel, W. K. (1997). Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: Drug and monetary rewards. Experimental and Clinical Psychopharmacology, 5, 256–262.

    PubMed  CAS  Google Scholar 

  • Maejima, T., Ohno-Shosaku, T., & Kano, M. (2001). Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals. Neuroscience Research, 40, 205–210.

    PubMed  CAS  Google Scholar 

  • Maldonado, R. (2002). Study of cannabinoid dependence in animals. Pharmacology & Therapeutics, 95, 153–164.

    CAS  Google Scholar 

  • Maldonado, R., Valverde, O., & Berrendero, F. (2006). Involvement of the endocannabinoid system in drug addiction. Trends in Neuroscience, 29, 225–232.

    CAS  Google Scholar 

  • Marsicano, G., Moosmann, B., Hermann, H., Lutz, B., & Behl, C. (2002). Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1. Journal of Neurochemistry, 80, 448–456.

    PubMed  CAS  Google Scholar 

  • Mathew, R. J., Tant, S., & Burger, C. (1986). Regional cerebral blood flow in marijuana smokers. British Journal of Addictions, 81, 567–571.

    CAS  Google Scholar 

  • Mathew, R. J., & Wilson, W. H. (1993). Acute changes in cerebral blood-flow after smoking marijuana. Life Sciences, 52, 757–767.

    PubMed  CAS  Google Scholar 

  • Mathew, R. J., Wilson, W. H., Chiu, N. Y., Turkington, T. G., Degrado, T. R., & Coleman, R. E. (1999). Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatrica Scandinavica, 100, 67–75.

    PubMed  CAS  Google Scholar 

  • Mathew, R. J., Wilson, W. H., Coleman, R. E., Turkington, T. G., & Degrado, T. R. (1997). Marijuana intoxication and brain activation in marijuana smokers. Life Sciences, 60, 2075–2089.

    PubMed  CAS  Google Scholar 

  • Mathew, R. J., Wilson, W. H., Humphreys, D. F., Lowe, J. V., & Wiethe, K. E. (1992). Regional cerebral blood flow after marijuana smoking. Journal of Cerebral Blood Flow and Metabolism, 12, 750–758.

    PubMed  CAS  Google Scholar 

  • Mathew, R. J., Wilson, W. H., & Tant, S. R. (1989). Acute changes in cerebral blood-flow associated with marijuana smoking. Acta Psychiatrica Scandinavica, 79, 118–128.

    PubMed  CAS  Google Scholar 

  • Mathew, R. J., Wilson, W. H., Turkington, T. G., & Coleman, R. E. (1998). Cerebellar activity and disturbed time sense after THC. Brain Research, 797, 183–189.

    PubMed  CAS  Google Scholar 

  • Mathew, R. J., Wilson, W. H., Turkington, T. G., Hawk, T. C., Coleman, R. E., DeGrado, T. R., et al. (2002). Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. Psychiatry Research: Neuroimaging, 116, 173–185.

    CAS  PubMed  Google Scholar 

  • Matochik, J. A., Eldreth, D. A., Cadet, J. L., & Bolla, K. I. (2005). Altered brain tissue composition in heavy marijuana users. Drug and Alcohol Dependence, 77, 23–30.

    PubMed  CAS  Google Scholar 

  • Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561–564.

    PubMed  CAS  Google Scholar 

  • McAllister, S. D., & Glass, M. (2002). CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids. Prostaglandins, Leukotrienes and Essential Fatty Acids, 66, 161–171.

    CAS  Google Scholar 

  • McDonald, J., Schleifer, L., Richards, J. B., & de Wit, H. (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology, 28, 1356–1365.

    PubMed  CAS  Google Scholar 

  • Mechoulam, R. (2002). Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. Prostaglandins Leukotrienes and Essential Fatty Acids, 66, 93–99.

    CAS  Google Scholar 

  • Mechoulam, R., Benshabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., et al. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology, 50, 83–90.

    PubMed  CAS  Google Scholar 

  • Mechoulam, R., & Gaoni, Y. (1967). The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Letters, 12, 1109–1111.

    PubMed  CAS  Google Scholar 

  • Mechoulam, R., & Hanus, L. (2000). A historical overview of chemical research on cannabinoids. Chemistry and Physics of Lipids, 108, 1–13.

    PubMed  CAS  Google Scholar 

  • Mechoulam, R., Panikashvili, D., & Shohami, E. (2002). Cannabinoids and brain injury: therapeutic implications. Trends in Molecular Medicine, 8, 58–61.

    PubMed  CAS  Google Scholar 

  • Medina, K. L., Schweinsburg, A. D., Cohen-Zion, M., Nagel, B. J., & Tapert, S. F. (2007). Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicology and Teratology, 29, 141–152.

    PubMed  CAS  Google Scholar 

  • Merlin, M. D. (2003). Archaeological evidence for the tradition of psychoactive plant use in the Old World. Economic Botany, 57, 295–323.

    Google Scholar 

  • Messinis, L., Kyprianidou, A., Malefaki, S., & Papathanasopoulos, P. (2006). Neuropsychological deficits in long-term frequent cannabis users. Neurology, 66, 737–739.

    PubMed  Google Scholar 

  • Milton, N. G. (2002). Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. Neuroscience Letters, 332, 127–130.

    PubMed  CAS  Google Scholar 

  • Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61–65.

    PubMed  CAS  Google Scholar 

  • National Drug Intelligence Center (2005). National Drug Threat Assessment 2005 U.S. Department of Justice.

  • O’Leary, D. S., Block, R. I., Flaum, M., Schultz, S. K., Boles Ponto, L. L., Watkins, G. L., et al. (2000). Acute marijuana effects on rCBF and cognition: A PET study. Neuroreport, 11, 3835–3841.

    PubMed  CAS  Google Scholar 

  • O’Leary, D. S., Block, R. I., Koeppel, J. A., Flaum, M., Schultz, S. K., Andreasen, N. C., et al. (2002). Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology, 26, 802–816.

    PubMed  CAS  Google Scholar 

  • O’Leary, D. S., Block, R. I., Turner, B. M., Koeppel, J., Magnotta, V. A., Ponto, L. B., et al. (2003). Marijuana alters the human cerebellar clock. Neuroreport, 14, 1145–1151.

    PubMed  Google Scholar 

  • Onaivi, E. S., Ishiguro, H., Gong, J. P., Patel, S., Perchuk, A., Meozzi, P. A., et al. (2006). Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Annals of the New York Academy of Sciences, 1074, 514–536.

    PubMed  CAS  Google Scholar 

  • Pertwee, R. G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacology and Therapeutics, 74, 129–180.

    PubMed  CAS  Google Scholar 

  • Petry, N. M., Bickel, W. K., & Arnett, M. (1998). Shortened time horizons and insensitivity to future consequences in heroin addicts. Addiction, 93, 729–738.

    PubMed  CAS  Google Scholar 

  • Pillay, S. S., Rogowska, J., Kanayama, G., Jon, D. I., Gruber, S., Simpson, N., et al. (2004). Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: An fMRI study. Drug and Alcohol Dependence, 76, 261–271.

    PubMed  Google Scholar 

  • Pope, H. G. (2002). Cannabis, cognition, and residual confounding. Journal of the American Medical Association, 287, 1172–1174.

    PubMed  Google Scholar 

  • Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58, 909–915.

    PubMed  Google Scholar 

  • Pope, H. G., Jr., Gruber, A. J., & Yurgelun-Todd, D. (1995). The residual neuropsychological effects of cannabis: the current status of research. Drug and Alcohol Dependence, 38, 25–34.

    PubMed  Google Scholar 

  • Pope, H. G. Jr., & Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association, 275, 521–527.

    PubMed  CAS  Google Scholar 

  • Porter, A. C., Sauer, J. M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J. Q., et al. (2002). Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. Journal of Pharmacology and Experimental Therapeutics, 301, 1020–1024.

    PubMed  CAS  Google Scholar 

  • Poulsen, H. A., & Sutherland, G. J. (2000). The potency of cannabis in New Zealand from 1976 to 1996. Science & Justice, 40, 171–176.

    Article  CAS  Google Scholar 

  • Quickfall, J., & Crockford, D. (2006). Brain neuroimaging in cannabis use: A review. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 318–332.

    PubMed  Google Scholar 

  • Ramaekers, J. G., Kauert, G., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., & Moeller, M. R. (2006). High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology, 31, 2296–2303.

    PubMed  CAS  Google Scholar 

  • Ramirez, B. G., Blazquez, C., Gomez del, P. T., Guzman, M., & de Ceballos, M. L. (2005). Prevention of Alzheimer’s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation. Journal of Neuroscience, 25, 1904–1913.

    PubMed  CAS  Google Scholar 

  • Ranganathan, M., & D’Souza, D. C. (2006). The acute effects of cannabinoids on memory in humans: A review. Psychopharmacology, 188, 425–444.

    PubMed  CAS  Google Scholar 

  • Rochford, J., Grant, I., & LaVigne, G. (1977). Medical students and drugs: Further neuropsychological and use pattern considerations. International Journal of the Addictions, 12, 1057–1065.

    PubMed  CAS  Google Scholar 

  • Rodgers, J. (2000). Cognitive performance amongst recreational users of “ecstasy”. Psychopharmacology, 151, 19–24.

    PubMed  CAS  Google Scholar 

  • Rojas, R., Riascos, R., Vargas, D., Cuellar, H., & Borne, J. (2005). Neuroimaging in drug and substance abuse part I: Cocaine, cannabis, and ecstasy. Topics in Magnetic Resonance Imaging, 16, 231–238.

    PubMed  Google Scholar 

  • SAMHSA. (2005). Summary of Findings from the 2005 National Household Survey on Drug Abuse. Rockville, MD, Office of Applied Studies. Ref Type: Generic.

  • Sarne, Y., & Keren, O. (2004). Are cannabinoid drugs neurotoxic or neuroprotective? Medical Hypotheses, 63, 187–192.

    PubMed  CAS  Google Scholar 

  • Sarne, Y., & Mechoulam, R. (2005). Cannabinoids: Between neuroprotection and neurotoxicity. Current Drug Targets CNS and Neurological Disorders, 4, 677–684.

    PubMed  CAS  Google Scholar 

  • Scallet, A. C., Uemura, E., Andrews, A., Ali, S. F., McMillan, D. E., Paule, M. G., et al. (1987). Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC). Brain Research, 436, 193–198.

    PubMed  CAS  Google Scholar 

  • Schweinsburg, A. D., Schweinsburg, B. C., Cheung, E. H., Brown, G. G., Brown, S. A., & Tapert, S. F. (2005). fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders. Drug and Alcohol Dependence, 79, 201–210.

    PubMed  Google Scholar 

  • Sneider, J. T., Pope, H. G., Jr., Silveri, M. M., Simpson, N. S., Gruber, S. A., & Yurgelun-Todd, D. A. (2006). Altered regional blood volume in chronic cannabis smokers. Experimental and Clinical Psychopharmacology, 14, 422–428.

    PubMed  CAS  Google Scholar 

  • Solowij, N. (1995). Do cognitive impairments recover following cessation of cannabis use? Life Sciences, 56, 2119–2126.

    PubMed  CAS  Google Scholar 

  • Solowij, N. (1998). Cannabis and cognitive functioning. New York: Cambridge University Press.

  • Solowij, N. (1999). Long-term effects of cannabis on the central nervous system. In H. Kalant, W. Corrigall, W. Hall, & R. Smart (Eds.), The health effects of cannabis (pp. 195–265). Toronto: Addiction Research Foundation.

    Google Scholar 

  • Solowij, N., Stephens, R. S., Roffman, R. A., Babor, T., Kadden, R., Miller, M., et al. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Journal of the American Medical Association, 287, 1123–1131.

    PubMed  Google Scholar 

  • Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., et al. (1995). 2-Arachidonoylgylcerol—A possible endogenous cannabinoid receptor-ligand in brain. Biochemical and Biophysical Research Communications, 215, 89–97.

    PubMed  CAS  Google Scholar 

  • Tanda, G., & Goldberg, S. R. (2003). Cannabinoids: Reward, dependence, and underlying neurochemical mechanisms—A review of recent preclinical data. Psychopharmacology, 169, 115–134.

    PubMed  CAS  Google Scholar 

  • Tunving, K., Thulin, S. O., Risberg, J., & Warkentin, S. (1986). Regional cerebral blood-flow in long-term heavy cannabis use. Psychiatry Research, 17, 15–21.

    PubMed  CAS  Google Scholar 

  • Tzilos, G. K., Cintron, C. B., Wood, J. B., Simpson, N. S., Young, A. D., Pope, H. G. Jr., et al. (2005). Lack of hippocampal volume change in long-term heavy cannabis users. American Journal of Addictions, 14, 64–72.

    Google Scholar 

  • United Nations Office on Drugs and Crimes. (2004). World Drug Report United Nations Publications.

  • Vanyukov, M. M., Tarter, R. E., Kirisci, L., Kirillova, G. P., Maher, B. S., & Clark, D. B. (2003). Liability to substance use disorders: 1. Common mechanisms and manifestations. Neuroscience and Biobehavioral Review, 27, 507–515.

    Google Scholar 

  • Verdejo-Garcia, A., Benbrook, A., Funderburk, F., David, P., Cadet, J. L., & Bolla, K. I. (2007). The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug and Alcohol Dependence, 90, 2–11.

    PubMed  Google Scholar 

  • Volkow, N. D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., Ivanovic, M., et al. (1991). Cerebellar metabolic-activation by delta-9-tetrahydro-cannabinol in human brain—A study with positron emission tomography and F-18 2-fluoro-2-deoxyglucose. Psychiatry Research-Neuroimaging, 40, 69–78.

    CAS  Google Scholar 

  • Volkow, N. D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., Valentine, A., et al. (1996). Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Research-Neuroimaging, 67, 29–38.

    CAS  Google Scholar 

  • Wachtel, S. R., ElSohly, M. A., Ross, S. A., Ambre, J., & de, W. H. (2002). Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology, 161, 331–339.

    PubMed  CAS  Google Scholar 

  • Wert, R. C., & Raulin, M. L. (1986). The chronic cerebral effects of cannabis use. II. Psychological findings and conclusions. International Journal of Addictions, 21, 629–642.

    CAS  Google Scholar 

  • Whitlow, C. T., Liguori, A., Livengood, L. B., Hart, S. L., Mussat-Whitlow, B. J., Lamborn, C. M., et al. (2004). Long-term heavy marijuana users make costly decisions on a gambling task. Drug and Alcohol Dependence, 76, 107–111.

    PubMed  Google Scholar 

  • Wiesbeck, G. A., & Taeschner, K. L. (1991). A cerebral computed tomography study of patients with drug-induced psychoses. European Archives of Psychiatry and Clininical Neuroscience, 241, 88–90.

    CAS  Google Scholar 

  • Wig, N. N., & Varma, V. K. (1977). Patterns of long-term heavy cannabis use in North India and its effects on cognitive functions: A preliminary report. Drug & Alcohol Dependence, 2, 211–219.

    Google Scholar 

  • Wilson, W., Mathew, R., Turkington, T., Hawk, T., Coleman, R. E., & Provenzale, J. (2000). Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study. Journal of Addictive Disease, 19, 1–22.

    CAS  Google Scholar 

  • Zuardi, A. W. (2006). History of cannabis as a medicine: A review. Revista Brasileira de Psiquiatria, 28, 153–157.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Illinois, Chicago, 1601 W. Taylor Street, MC 912, Chicago, IL, 60612, USA

    Raul Gonzalez

Authors
  1. Raul Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raul Gonzalez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonzalez, R. Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance. Neuropsychol Rev 17, 347–361 (2007). https://doi.org/10.1007/s11065-007-9036-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11065-007-9036-8

Keywords

Search

Navigation